γ-Aminobutyric acid (GABA) neurons terminating in the hypothalamus have been implicated in the neuroendocrine regulation of reproductive hormones, particularly luteinizing hormone (LH) and prolactin. The aim of this study was to examine whether GABAergic neuronal activity in the hypothalamus was modified during lactation, and whether any observed changes correlated with changes in secretion of these hormones. Animals were divided into three experimental groups: diestrous controls, lactating with pups present (with pups), and lactating with pups removed for 4 h (without pups). Animals were decapitated either without treatment, or 60 min after inhibition of GABA degradation by aminooxyacetic acid (AOAA) (100 mg/kg, i.p.). The rate of GABA accumulation in the tissue after AOAA is a measure of GABA turnover. GABA turnover was estimated in 13 microdissected brain regions, and serum prolactin and LH measured by radioimmunoassay. Suckling was associated with significantly increased prolactin and significantly decreased LH compared with diestrous rats. In lactating rats with pups, GABA turnover was significantly increased in the cingulate cortex compared with diestrous rats. GABA turnover was significantly increased in the ventrolateral preoptic nucleus of lactating rats with pups compared with diestrous rats or lactating rats without pups. There was significantly lower GABA turnover in the anterior hypothalamic area, ventromedial and dorsomedial hypothalamic nuclei in lactating rats without pups compared with diestrous rats. There were no significant changes in other brain regions examined. The results demonstrate that activity of GABAergic neurons in specific parts of the hypothalamus and cerebral cortex is altered during lactation.

Keywords:
Suckling, Gonadotropins, Prolactin, Gonadotropin-releasing hormone, =γ-Aminobutyric acid, Lactation
1.
Howie PW: Natural regulation of fertility. Br Med Bull 1993;49:182–199.
2.
McNeilly AS: Suckling and the control of gonadotropin secretion; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, vol 2, pp 1179–1212.
3.
Léránth C, MacLusky NJ, Sakamoto H, Shanabrough M, Naftolin F: Glutamic acid decarboxylase-containing axons synapse on LHRH neurons in the rat medial preoptic area. Neuroendocrinology 1985;40:536–539.
4.
Petersen SL, McCrone S, Coy D, Adelman JP, Mahan LC: GABAA receptor subunit mRNAs in cells of the preoptic area: Colocalization with LHRH mRNA using dual label in situ hybridization histochemistry. Endocr J 1993;1:29–34.
5.
Kordon C, Drouva SV, Martinez de la Escalera G, Weiner RI: Role of classic and peptide neuromediators in the neuroendocrine regulation of luteinizing hormone and prolactin; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, vol 1, pp 1621–1681.
6.
Sagrillo CA, Grattan DR, McCarthy MM, Selmanoff M: Hormonal and neurotransmitter regulation of GnRH gene expression and related reproductive behaviors. Behav Gen 1996;26:241–277.
7.
Herbison AE: Estrogen regulation of GABA transmission in rat preoptic area. Brain Res Bull 1997;44:321–326.
8.
Herbison AE: Multimodal influence of estrogen upon gondatropin-releasing hormone neurons. Endocr Rev 1998;19:302–330.
9.
Grattan DR, Selmanoff M: Castration-induced decrease in the activity of medial preoptic and tuberoinfundibular GABAergic neurons is prevented by testosterone. Neuroendocrinology 1994;60:141–149.
10.
Mansky T, Mestres-Ventura P, Wuttke W: Involvement of GABA in the feedback action of estradiol on gonadotropin and prolactin release: Hypothalamic GABA and catecholamine turnover rates. Brain Res 1982;231:353–364.
11.
Herbison AE, Heavens RP, Dyer RG: Oestrogen modulation of excitatory A1 noradrenergic input to rat medial preoptic gamma-aminobutyric acid neurons demonstrated by microdialysis. Neuroendocrinology 1990;52:161–168.
12.
Herbison AE, Heavens RP, Dye S, Dyer RG: Acute actions of oestrogen on medial preoptic gamma-aminobutyric acid neurons: Correlation with oestrogen-negative feedback on luteinizing hormone secretion. J Neuroendocrinol 1991;3:101–106.
13.
Qureshi GA, Hansen S, Södersten P: Offspring control of cerebrospinal fluid GABA concentrations in lactating rats. Neurosci Lett 1987;75:85–88.
14.
Locatelli V, Apud JA, Gudelsky GA, Cocchi D, Masotto C, Casanueva F, Racagni GM: Prolactin in cerebrospinal fluid increases the synthesis and release of hypothalamic γ-aminobutyric acid. J Endocrinol 1985;106:323–328.
15.
Felman K, Tappaz M: GABAergic biochemical parameters of the tuberoinfundibular neurons following chronic hyperprolactinemia. Neuroendocrinology 1989;49:580–585.
16.
Kolbinger W, Beyer C, Fohr K, Reisert I, Pilgrim C: Diencephalic GABAergic neurons in vitro respond to prolactin with a rapid increase in intracellular free calcium. Neuroendocrinology 1992;56:148–152.
17.
Grattan DR, Selmanoff M: Regional variation in γ-aminobutyric acid turnover: Effect of castration on γ-aminobutyric acid turnover in microdissected brain regions of the male rat. J Neurochem 1993;60:2254–2264.
18.
Palkovits M, Brownstein MJ: Maps and Guide to Microdissection of the Rat Brain. New York, Elsevier, 1988.
19.
Baxter RC: Simplified approach to confidence limits in radioimmunoassay. Clin Chem 1980;26:763–765.
20.
Neill JD, Nagy GM: Prolactin secretion and its control; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, vol 1, pp 1833–1860.
21.
Grattan DR, Selmanoff M: Prolactin- and testosterone-induced inhibition of LH secretion after orchidectomy: Role of preoptic and tuberoinfundibular γ-aminobutyric acidergic neurones. J Endocrinol 1994;143:165–174.
22.
Grandison L, Guidotti A: γ-Aminobutyric acid receptor function in rat anterior pituitary: Evidence for control of prolactin release. Endocrinology 1979;105:754–759.
23.
Lux-Lantos V, Somoza G, Rey E, Libertum C: Further evidence for the inhibitory action of baclofen on a prolactin-releasing factor. Proc Soc Exp Biol Med 1991;197:337–341.
24.
Moore KE, Lookingland KJ: Dopaminergic neuronal systems in the hypothalamus; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 245–256.
25.
Donoso AO, Banzan AM: Effects of increase of brain GABA levels on the hypothalamic-pituitary-luteinizing hormone axis in rats. Acta Endocrinol 1984;106:298–304.
26.
Grattan DR, Rocca MS, Strauss KI, Sagrillo CA, Selmanoff M, McCarthy MM: GABAergic neuronal activity and mRNA levels for both forms of glutamic acid decarboxylase (GAD65 and GAD67) are reduced in the diagonal band of Broca during the afternoon of proestrus. Brain Res 1996;733:46–55.
27.
Löscher W, Hönack D, Gramer M: Use of inhibitors of γ-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: A reevaluation of aminooxyacetic acid. J Neurochem 1989;53:1737–1750.
28.
Fox S, Smith M: The suppression of pulsatile luteinizing hormone secretion during lactation in the rat. Endocrinology 1984;115:2045–2051.
29.
Lee LR, Haisenleder DJ, Marshall JC, Smith MS: Effects of progesterone on pulsatile luteinizing hormone (LH) secretion and LH subunit messenger ribonucleic acid during lactation in the rat. Endocrinology 1989;124:2128–2134.
30.
Yoo MJ, Searles R, He JR, Shen WB, Grattan DR, Selmanoff M: Castration rapidly decreases hypothalamic γ-aminobutyric acidergic neuronal activity in both male and female rats. Brain Res 2000;878:1–10.
31.
Cohen-Becker IR, Selmanoff M, Wise PM: Hyperprolactinemia alters the frequency and amplitude of pulsatile luteinizing hormone secretion in the ovariectomized rat. Neuroendocrinology 1986;42:328–333.
32.
Fox SR, Hoefer MT, Bartke A, Smith MS: Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat. Neuroendocrinology 1987;46:350–359.
33.
Park SK, Selmanoff M: Dose-dependent suppression of postcastration luteinizing hormone secretion exerted by exogenous prolactin administration in male rats: A model for studying hyperprolactinemic hypogonadism. Neuroendocrinology 1991;53:404–410.
34.
Park SK, Keenan MW, Selmanoff M: Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats. Neuroendocrinology 1993;58:448–453.
35.
Cagampang FRA, Maeda KI, Tsukamura H, Ohkura S, Ota K: Involvement of ovarian steroids and endogenous opioids in the fasting-induced suppression of pulsatile LH release in ovariectomized rats. J Endocrinol 1991;129:321–328.
36.
Quesnel H, Prunier A: Endocrine bases of lactational anoestrus in the sow. Reprod Nutr Dev 1995;35:395–414.
37.
Smart D, Singh I, Smith RF, Dobson H: Opioids and suckling in relation to inhibition of oestradiol-induced LH secretion in postpartum ewes. J Reprod Fertil 1994;101:115–119.
38.
Walker CD, Dallman MF, Palmer AA, Steele MK: Involvement of central corticotropin-releasing factor in suckling-induced inhibition of luteinizing hormone secretion in lactating rats. J Neuroendocrinol 1993;5:451–459.
39.
Smith MS: The relative contribution of suckling and prolactin to the inhibition of gonadotropin secretion during lactation in the rat. Biol Reprod 1978;19:77–83.
40.
Maeda K, Uchida E, Tsukamura H, Ohkura N, Ohkura S, Yokoyama A: Prolactin does not mediate the suppressive effect of the suckling stimulus on luteinizing hormone secretion in ovariectomized lactating rats. Endocrinol Jpn 1990;37:405–411.
41.
Tsukamura H, Ohkura S, Coen CW, Maeda KI: The paraventricular nucleus and corticotrophin-releasing hormone are not critical in suppressing pulsatile LH secretion on ovariectomized lactating rats. J Endocrinol 1993;137:291–297.
42.
McGuire MK, Myers TR, Butler WR, Rasmussen KM: Naloxone administration does not relieve the inhibition of gonadotropin release in food-restricted, lactating rats. J Nutr 1996;126:2113–2119.
43.
Olds J: Lesions, Drives and Reinforcements: Behavioral Studies of Hypothalamic Functions. New York, Raven Press, 1977, pp 37–51.
44.
Oparil S, Chen YF, Peng N, Wyss JM: Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension. Front Neuroendocrinol 1996;17:212–246.
45.
Pfaff DW, Schwartz-Giblin S, McCarthy MM, Kow LM: Cellular and molecular mechanisms of female reproductive behaviours; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, vol 2, pp 107–220.
46.
McCarthy MM, Masters DB, Fiber JM, Lopez-Colome AM, Beyer C, Komisaruk BR, Feder HH: GABAergic control of receptivity in the female rat. Neuroendocrinology 1991;53:473–479.
47.
Nobrega JN, Snow J, Dixon LM, Coscina DV: Graded increases in brain GABA: Differential effects of feeding and other behaviours in rats. Behav Brain Res 1988;31:135–147.
48.
Rattan AK, Mangat HK: Electrical activity and feeding correlates of intracranial hypothalamic injection of GABA, muscimol and picrotoxin in the rats. Acta Neurobiol Exp 1990;50:23–36.
49.
Coscina DV, Castonguay TW, Stern JS: Effects of increasing brain GABA on the meal patterns of genetically obese vs. lean Zucker rats. Int J Obes Relat Metab Disord 1992;16:425–433.
50.
Hansen S, Ferreira A: Effects of bicuculline infusions in the ventromedial hypothalamus and amygdaloid complex on food intake and affective behavior in mother rats. Behav Neurosci 1986;100:410–415.
51.
Lenin Kamatchi G, Veeraragavan K, Chandra D, Bapna JS: Antagonism of acute feeding response to 2-deoxyglucose and 5-thioglucose by GABA antagonists: The relative role of ventromedial and lateral hypothalamus. Pharmacol Biochem Behav 1986;25:59–62.
52.
Beverly JL, Beverly MF, Meguid MM: Alterations in extracellular GABA in the ventral hypothalamus of rats in response to acute glucoprivation. Am J Physiol 1995;269:R1174–R1178.
53.
Grossman BM, Devore ML, Kelso EW, Martin RJ: Effect of glucose and 2-deoxyglucose on hypothalamic GABA release in lactating rats. Physiol Behav 1997;61:169–173.
54.
Gies U, Theodosis DT: Synaptic plasticity in the rat supraoptic nucleus during lactation involves GABA innervation and oxytocin neurons: A quantitative immunocytochemical analysis. J Neurosci 1994;14:2861–2869.
55.
Moos FC: GABA-induced facilitation of the periodic bursting activity of oxytocin neurones in suckled rats. J Physiol (Lond) 1995;488:103–114.
56.
Voisin DL, Herbison AE, Poulain DA: Central inhibitory effects of muscimol and bicuculline on the milk ejection reflex in the anaesthetized rat. J Physiol (Lond) 1995;483:211–224.
57.
El Majdoubi M, Poulain DA, Theodosis DT: Lactation-induced plasticity in the supraoptic nucleus augments axodendritic and axosomatic GABAergic and glutamatergic synapse: An ultrastructural analysis using the disector method. Neuroscience 1997;80:1137–1147.
58.
Voisin DL, Chapman C, Poulain DA, Herbison AE: Extracellular GABA concentrations in rat supraoptic nucleus during lactation and following haemodynamic changes: An in vivo microdialysis study. Neuroscience 1994;63:547–558.
59.
Abbud R, Smith MS: Altered luteinizing hormone and prolactin responses to excitatory amino acids during lactation. Neuroendocrinology 1993;58:454–464.
60.
Abbud R, Hoffman GE, Smith MS: Cortical refractoriness to N-methyl-D,L-aspartic acid stimulation in the lactating rat: Recovery after pup removal and blockade of progesterone receptors. Brain Res 1993;604:16–23.
61.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 3. San Diego, Academic Press, 1997.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.